During passage through the gastrointestinal tract, enterohaemorrhagic Escherichia coli (EHEC) encounters numerous stresses, each producing unique antimicrobial conditions. Beyond surviving these stresses, EHEC may also use them as cues about the local microenvironment to modulate its virulence. Of particular interest is how exposure to changing concentrations of short-chain fatty acids (SCFAs) associated with passage through the small and large intestines affects EHEC virulence, as well as flagella expression and motility specifically. In this study, we investigate the impact of exposure to SCFA mixes simulating concentrations and compositions within the small and large intestines on EHEC flagella expression and function. Using a combination of DNA microarray, quantitative real-time PCR, immunoblot analysis, flow cytometry and motility assays, we show that there is a marked, significant upregulation of flagellar genes, the flagellar protein, FliC, and motility when EHEC is exposed to SCFA mixes representative of the small intestine. By contrast, when EHEC is exposed to SCFA mixes representative of the large intestine, there is a significant downregulation of flagellar genes, FliC and motility. Our results demonstrate that EHEC modulates flagella expression and motility in response to SCFAs, with differential responses associated with SCFA mixes typical of the small and large intestines. This research contributes to our understanding of how EHEC senses and responds to host environmental signals and the mechanisms it uses to successfully infect the human host. Significantly, it also suggests that EHEC is using this key gastrointestinal chemical signpost to cue changes in flagella expression and motility in different locations within the host intestinal tract.
INTRODUCTION
Enterohaemorrhagic Escherichia coli (EHEC), including serotype O157 : H7, is a food-borne enteric pathogen that causes severe illness resulting in diarrhoea, haemorrhagic colitis, and potentially leading to life-threatening sequelae including haemolytic uremic syndrome. EHEC, like all enteric pathogens, must traverse the human gastrointestinal tract (GIT) to reach the preferred site of colonization in the large intestine. The human GIT presents a host of hostile microenvironments to EHEC, including changing profiles of short-chain fatty acids (SCFA) associated with passage through the small and large intestines. SCFAs are fermentation end products of the metabolism of dietary fibre by the GIT microbiota. They are composed primarily of acetate, propionate and butyrate and they range in concentration and composition along the GIT tract with lower concentrations in the small intestine (sSCFA) and higher concentrations in the large intestine (lSCFA) (Herold et al., 2009) . The total SCFA concentration is lowest in the distal ileum, ranging from 20 to 40 mM, and increases through the large intestine with concentrations ranging between 70 and (Argenzio et al., 1974; Cummings et al., 1987; Macfarlane et al., 1992; Roy et al., 2006; Wong et al., 2006) . These concentrations as well as the individual SCFA ratios within the mixtures depend on a number of factors including the species and numbers of gut microflora present in the small and large intestines as well as the diet and gut transit time (Roy et al., 2006; Wong et al., 2006) . Bacteroidetes tend to produce primarily acetate and propionate, while Firmicutes tend to produce more butyrate (den Besten et al., 2013) . Diet can also influence SCFA production and composition with different types of carbohydrates generating different SCFA ratios (Henningsson et al., 2003) . Fermentation of starch, wheat and oat bran tends to yield more butyrate, while fermentation of pectin typically yields more acetate (Cummings & Macfarlane, 1991; Gilbert et al., 2008; Roy et al., 2006) . Interestingly, modifying SCFA levels by altering dietary levels of cellulose and carbohydrates has been proposed as a way to manipulate the gut microbiota of food-producing animals to prevent pathogen colonization (Bailey et al., 1991; Durant et al., 1999; Fukata et al., 1999; Naughton et al., 2001) .
SCFAs play an important role in maintaining colonic health and decreasing the risk of colon cancer, inflammatory bowel disease and possibly even cardiovascular disease (Roy et al., 2006) . Butyrate is a major energy source for the colonic epithelium and has been shown to promote cell differentiation, cell cycle arrest and apoptosis of transformed colonocytes (Tobe et al., 2011; Wong et al., 2006) . Butyrate has also been reported to protect epithelial cell lines from Campylobacter invasion and translocation (Van Deun et al., 2008) . Furthermore, higher levels of SCFAs have been shown to inhibit growth of some pathogens including Salmonella (Bohnoff et al., 1964a; Meynell, 1963) . In fact, mice treated with streptomycin have decreased SCFA levels, reduced numbers of colonic flora and are more susceptible to Salmonella typhimurium infection (Bohnoff et al., 1964b; Meynell & Subbaiah, 1963; Meynell, 1963) .
However, research has also demonstrated that SCFAs can serve as signals for virulence gene regulation in a number of enteric pathogens (Arnold et al., 2001; Gantois et al., 2006; Herold et al., 2009; Kwon & Ricke, 1998; Lawhon et al., 2003; Shin et al., 2002; Tobe et al., 2011; Sun & O'Riordan, 2013) . Acetate through the production of acetyl phosphate provides a signal for invasion gene expression in Salmonella enterica serovar Typhimurium, but interestingly only at concentrations typically found in the distal ileum (15 and 30 mM), the preferred site of colonization (Lawhon et al., 2003) . In that same study, butyrate and propionate at ileal concentrations had the opposite effect. The authors also reported that an SCFA combination similar to that found in the ileum enhanced invasion gene expression, while an SCFA mix representative of the colon had the opposite effect.
Exposure of EHEC to 20 mM butyrate, a concentration similar to that of the large intestine, was reported to enhance expression of virulence genes involved in epithelial cell adhesion including the locus of enterocyte effacement (LEE) 1 operon and genes involved in motility (Tobe et al., 2011) . On the other hand, the same concentrations of acetate or propionate did not have this effect. The butyrate response was shown to be dependent on sensing through the regulator, leucine-responsive regulatory protein, Lrp (Nakanishi et al., 2009) . Studies of SCFA adaptation responses in nonpathogenic E. coli have also reported increases in flagellar gene expression and motility associated with adaptation to either 20 mM acetate or propionate, concentrations that are more similar to that of the small intestine (Polen et al., 2003) . SCFAs have also been reported to alter EHEC adhesion to epithelial cells. In one study, the expression of the iha gene that encodes an adherence-conferring outer membrane protein of both (LEE)-positive and LEE-negative EHEC was found to be modulated in response to colonic concentrations of SCFAs (Herold et al., 2009 ).
Taken together, these studies suggest that SCFAs may play an important role in modulating virulence factor expression in enteric pathogens and that concentrations as well as composition of SCFA mixes may be critical factors in this regulation. Since EHEC colonizes the large intestine, the change in SCFA concentrations and ratios along the small and large intestines may be particularly important in cueing expression of virulence factors and modulating pathogen behaviour. Whilewe have reports on the influence of individual SCFAs on EHEC virulence, we do not have a full understanding of how exposure to changing concentrations and compositions of SCFA mixes associated with transit through the intestinal tract influences EHEC virulence. In this study, we investigate the response of EHEC to SCFA mixes and individual SCFAs at concentrations typically found in the small and large intestines and we examine the influence of SCFAs on EHEC flagella expression and motility. We show for the first time that EHEC upregulates flagella expression and motility when exposed to SCFA mixes typical of the small intestine and that it, conversely, downregulates flagella expression and motility when exposed to SCFA mixes typical of the large intestine.
METHODS
Bacterial strains and culture conditions. Both E. coli O157 : H7 strains, EDL933 and 86-24, were used in this study. Bacterial glycerol stocks were maintained at À80 C and were streaked onto LB agar (BioShop) prior to use in order to obtain single colonies. Overnight cultures were prepared by inoculating single colonies into LB broth, which was incubated at 37 C with shaking.
SCFA treatment of EHEC. For 30 mM SCFA treatment, the LB overnight culture was resuspended in LB containing 100 mM MOPS (morpholinepropanesulfonic acid, pH 6.7) and 30 mM SCFA mixture (25 mM sodium acetate, 2.5 mM sodium propionate and 2.5 mM sodium butyrate) (Herold et al., 2009) to an OD 600 of 0.05 and then incubated at 37 C statically with 5 % CO 2 to late log phase (OD 600 of approximately 1.0). The 30 mM and 172 mM NaCl controls were treated similarly. For the 172 mM SCFA mixture (95 mM sodium acetate, 60 mM sodium propionate and 17 mM sodium butyrate) (Herold et al., 2009 ), due to the prolonged lag phase of EHEC incubated with this mixture, the LB overnight culture was resuspended in LB containing 100 mM MOPS (pH 6.7) to an OD 600 of 0.2, subcultured for 2 h, and then the culture continued in 172 mM SCFA mixture (in LB with MOPS) at 37 C with 5 % CO 2 to late log phase (OD 600 =1.0). All subcultures were grown statically with 5 % CO 2 , which has been reported to approximate conditions in the intestinal lumen (Rosenshine et al., 1996) .
For the microarray studies, bacteria were cultured as described above except that they were subcultured in Dulbecco's minimal essential medium (DMEM) containing 4.5 g l À1 glucose, with L-glutamine, sodium pyruvate, 100 mM MOPS (pH 6.7) and either one of the SCFA or NaCl treatments. Since DMEM subculture has been reported to enhance the expression of virulence factors (Rosenshine et al., 1996) , it was used for the initial microarray studies. In the subsequent real-time PCR, immunoblot and flow cytometry experiments, we used LB as the subculture media since it showed similar changes in flagella expression to the microarray data and generated more reproducible motility results.
DNA microarray analysis of gene expression. The treatment groups included treatment with one of 30 mM SCFA mix or 30 mM NaCl control, or 172 mM SCFA mix or 172 mM NaCl control as described in the SCFA treatment of EHEC section. Each treatment included four independent biological replicates. RNA purification was performed as described previously (Kus et al., 2011) . The quality and integrity of total RNA in each sample was verified using an Agilent Technologies Bioanalyser 2100. An Agilent E. coli Gene Expression 8Â15K Microarray with 10 691 probes for strains, K12-MG1655, O157 : H7 EDL933, O157 : H7 VT2-Sakai and CFT073 (Agilent Product number G4813A) was used for gene expression analysis. The cDNA generation and hybridization of the microarrays were performed by the Princess Margaret Genomics Centre according to standard protocols. Data were checked for overall quality using R (v2.14.1) with the Bioconductor framework and the Array Quality Metrics package. Data were imported into Genespring v12.1. The data were normalized using the recommended Agilent spatial detrending method, and all data analysis and visualization were performed on normalized log2 transformed data. In the case of the 172 mM treatment, two of the four replicates were identified as outliers and were excluded from subsequent analysis. Data for each treatment group were filtered to remove the confounding effect probes that showed no signal. Only probes that were in the upper 80th percentile of the distribution of intensities in 100 % of any of the sample groups were allowed to pass this filtering. For the 30 mM condition, the final set contained 8513 probes and for the 172 mM condition, the final set contained 8643 probes. Significant genes within each treatment were identified using an unpaired t-test (P<0.05). The complete data set is available under NCBI Gene Expression Omnibus Series accession number GSE79509.
Quantitative real-time PCR. Following SCFA stress, total RNA was isolated using a GeneJet RNA Purification kit (ThermoFisher Scientific) and converted into cDNA using the iScript cDNA synthesis kit (BioRad) according to manufacturer's instructions. Gene expression was analysed using primers against gapA (control) fliC, flhC, flhD, motAB, cheW and cheA (for primer sequences, see Table 1 ) and using Roche LightCycler FastStart DNA Master SYBR Green I and Roche LightCycler 2.0 Instrument (Roche). At least three individual experiments were carried out for each primer set.
Immunoblot analysis of FliC expression. In order to determine H7 (FliC) protein expression, immunoblot analysis was used. Following SCFA stress, bacteria were collected from culture using centrifugation at 3500 rpm for 10 min at 4 C, washed twice in 1Â PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 and 1.8 mM KH 2 PO 4 ) and resuspended in 1Â SDS sample buffer [10 % glycerol, 60 mM Tris/HCl (pH 6.8), 2 % SDS, 0.01 % bromophenol blue and 1.25 % b-mercaptoethanol]. Samples were then run on 10 % SDS-PAGE and transferred onto a 0.45 µm Immobilon-P PVDF membrane (EMD Millipore). Membranes were blocked in 1 % tris buffered saline with Tween 20+ milk for 1 h at room temperature with shaking and incubated overnight in either anti-H7 (1 : 500 dilution; Denka-Seiken) or anti-DnaK (1 : 10 000 dilution; Enzo Life Sciences). This was followed by incubation with a horseradish peroxidase-conjugated secondary antibody and visualization using enhanced chemiluminescent (ECL) detection.
Immunofluorescent staining of flagella. Following SCFA stress, 50l of bacterial suspension was placed onto a glass coverslip (18 mm diameter) and allowed to settle for 10 min at room temperature. Bacteria were then fixed in 4 % paraformaldehyde for 30 min at 37 C, washed twice in PBS and then blocked in PBS containing 4 % BSA for 30 min at room temperature. The washed bacteria were then incubated for 1 h at 37 C with anti-H7 (1 : 70 dilution), washed twice in PBS and then incubated with an Alexa Fluor 488-conjugated secondary antibody (1 : 5000 dilution) for 1 h at room temperature. The coverslips were washed twice, incubated with DAPI for 5 min at room temperature and mounted onto glass slides using Dako mounting medium (Dako Agilent Pathology Solutions). The prepared slides were visualized using an Olympus 1X83 Inverted Microscope linked to a Hamamatsu ORCA-Flash 4.0 digital camera (Olympus) at Â100 magnification.
Flow cytometry analysis of flagella expression. Protein expression of H7 (FliC) was also assessed by flow cytometry. SCFA-stressed EHEC was pelleted at 5000 rpm for 10 min, washed with Gibco Hanks' balanced salts solution (HBSS) (Life Technologies) and then incubated with anti-H7 (1 : 50 dilution) for 30 min at 4 C followed by a wash with HBSS. EHEC was then incubated with an Alexa Fluor 488-conjugated secondary antibody (Life Technologies) for 20 min at 4 C, washed with HBSS and fixed with 2 % paraformaldehyde for 15 min at room temperature followed by quenching with glycine and a final wash with HBSS. Flow cytometry was conducted using a BD LSRFortessa X-20 cell analyser (St Michael's Hospital) to measure the fluorescence intensity of approximately 10 000 cells for each condition. Data were analysed using FCS Express 5 (De Novo Software). Flow cytometric analysis was repeated at least three times.
Motility assays. The impact of SCFA treatment on EHEC motility was assessed by soft agar motility assay using 0.25 % Bacto tryptone agar plates supplemented with the indicated SCFA mixtures. Two microlitres of EHEC incubated with the corresponding SCFA treatment was spotted onto the soft agar plates, and the diameter of the motility halo was measured after 12 h incubation at 37 C. Motility assays were repeated at least three times for each condition. In order to control for the differences in growth that may affect halo sizes, we assessed the c.f.u. count for each of the motility halos by homogenizing the halos, serially diluting and plate counting the homogenates and then comparing the c.f.u. counts.
Statistical analysis. All data are shown as means±SE of the means (SEM values). Statistical significance of differences among sample groups was analysed using unpaired t-test or two-way ANOVA. Data analysed with two-way ANOVA were subjected to a post hoc Tukey's test. Statistical analysis was performed using GraphPad Prism v6.0. A P value of <0.05 was considered significant.
RESULTS

DNA microarray analysis of SCFA-treated EHEC
The transcriptome of EHEC O157 : H7 (strain EDL933) was analysed under two different SCFA treatment protocols; the full data set is available through the GEO database (GEO accession no. GSE79509). For each treatment, the expression of each gene was normalized to its expression in the relevant NaCl control conditions. With a cut-off value of 2 for the fold change in expression (P<0.05), we found that 104 genes were upregulated and 106 genes were downregulated twofold or more after exposure to sSCFA relative to its NaCl control (Table 2 ). In contrast, 143 genes were upregulated and 214 genes were downregulated after exposure to lSCFA relative to its NaCl control. By contrast, there was no significant change in the expression of the housekeeping gene gapA (encoding glyceraldehyde-3-phosphate dehydrogenase), either by microarray or by real-time PCR analysis (data not shown). Of particular note, the expression of the vast majority of flagellar genes was differentially regulated by the two treatments, with flagellar genes being upregulated 1.5-fold to 4.3-fold by sSCFA and downregulated 3-fold to 23-fold by lSCFA (Table 3) . Quantitative real-time PCR (qRT-PCR) confirmed these changes for selected flagellar genes including flhC and flhD (the master regulatory genes), as well as motility genes (motAB) and chemotaxis gene (cheA), all of which were significantly upregulated with sSCFA treatment relative to lSCFA treatment (Fig. 1a,  b) . Interestingly, qRT-PCR showed no significant change in either the major structural subunit, fliC, or the chemotaxis gene, cheW, under sSCFA treatment relative to the lSCFA treatment, results that were consistent with the microarray data.
Treatment with sSCFA also upregulated numerous genes associated with methionine metabolism including the met operon (1.7-fold to 3.8-fold) and the ybd operon that encodes aminotransferases, particularly ybdL, methionine transferase (2.5-fold). This finding is consistent with reports that methionine metabolism is disturbed by exposure to acetate, the most abundant SCFA in the mix (Roe et al., 2002) . Also, upregulated (3.2-to 4-fold) under sSCFA conditions were genes encoded by the sdh operon involved in succinate metabolism that is associated with acetate metabolism (Cecchini et al., 2002; Park et al., 1995) . The rcsABC operon, required for acid resistance, was upregulated 1.2-fold to 2.1-fold under sSCFA treatment as were genes mat ABC (1.9-fold to 2.1-fold) that encode a type 1 fimbrial structure reported to be regulated by RcsB (Lehti et al., 2012) . By contrast, genes upregulated in the lSCFA treatment included general stress response genes associated with acid resistance (hdeD, 3.8-fold; ECs4391, 3.9-fold) (Masuda & Church, 2003) , transport, propionate (mhpC, 3.7-fold) (Manso et al., 2009 ) and fumarate metabolism (fdrA and fdrB, 2.3-fold) (Westenberg et al., 1993) , superoxide dismutase (CuZn-superoxide dismutase, 2.9-fold) and multidrug resistance as well as the leuO (2.11-fold), the expression of which has previously been shown to be induced by butyrate (Stoebel et al., 2008) .
Flagella are upregulated under sSCFA and downregulated under lSCFA
Based on the microarray evidence of flagella gene regulation by the two different SCFA mixes, we evaluated flagella expression under the two treatments by immunoblot analysis, immunofluorescent microscopy and flow cytometry. Immunoblot analysis of flagella expression by anti-H7 (FliC) confirmed a strong, significant 3.7-fold increase under 30 mM SCFA (sSCFA) relative to the 172 mM SCFA (lSCFA) treatment sample (Fig. 2a, b) . When compared to the respective NaCl controls, immunoblot analysis of FliC showed a 4.8-fold increase for 30 mM SCFA (sSCFA) relative to its 30 mM NaCl control and a small upregulation (1.3-fold) of FliC in 172 mM SCFA relative to its NaCl control, suggesting that FliC expression is not responding to osmolarity changes alone. Immunofluorescent microscopic analysis was consistent with the immunoblot analysis showing clearly evident flagella in the 30 mM SCFA treatment group but no detectable evidence of flagella in the 172 mM SCFA group (Fig. 2c) . Flow cytometric analysis also confirmed the immunoblot data, showing a significant increase in the proportion of EHEC expressing higher levels of flagella (35 %) under 30 mM SCFA mix relative to that under 172 mM SCFA mix (9.5 %) (Fig. 3) . With both the fluorescent microscopy results and the flow cytometric data, there was a modest level of FliC expression in the 30 mM NaCl control and virtually none in the 172 mM NaCl control. However, FliC expression under 30 mM SCFA treatment was always significantly higher than either the 30 mM or 172 mM NaCl control. While we cannot rule out a contribution of an osmolarity effect, particularly at the higher SCFA mix concentration, collectively the data suggest that osmolarity is not the defining factor in FliC expression.
Following the evaluation of responses to the two SCFA mixes, we also wanted to assess the same responses to the individual SCFAs at the respective total concentrations of each of the mixes. When EHEC was treated with the individual SCFAs relative to their corresponding SCFA mix, expression levels of FliC, as determined by immunoblot, were similar to that for the corresponding mix (Fig. 4) 
EHEC motility is modulated in response to changing SCFA mixes
We next assessed the motility of EHEC under the two different treatments using a soft agar motility assay. We saw a significant upregulation of motility in the 30 mM SCFAtreated sample and, by contrast, saw a significant downregulation of motility in the 172 mM SCFA relative to both the corresponding NaCl control and the 30 mM SCFAtreated sample (Fig. 5) . These results are consistent with the genetic, immunoblot and flow cytometric data showing a significant downregulation of flagella genes and proteins at 172 mM SCFA. DNA microarray analysis of flagellar gene expression showed significant upregulation for the 30 mM SCFA treatment, with an average upregulation of 2.38-fold relative to the NaCl control, results that were confirmed for FliC protein by immunoblot and flow cytometry. Since differences in motility can also reflect differences in growth rates, we strove to minimize changes in growth rate under the two treatments first by ensuring that both treatment samples were cultured to late log phase, as per the SCFA treatment protocol, which required additional time for the 172 mM SCFA treatment. Secondly, we determined the c.f.u. count for each motility halo at the end of the motility assay for each treatment group. Based on two independent experiments with six replicates each, we found no significant differences between c.f.u. 'halo' counts for the 30 mM SCFA and 172 mM SCFA treatment groups or between the SCFA treatment groups and their respective NaCl controls (P<0.05, two-way ANOVA with post-hoc Tukey's test), suggesting that differences in growth rates during the motility assays did not play a significant role in the differential motility results. We noted that the fold changes in motility were smaller than those determined for the FliC protein expression through immunoblot and flow cytometry analysis. However, the changes in motility gene expression (motAB and che genes) indicated by the microarray and qRT-PCR analysis were modest to insignificant, which may also explain the less dramatic differences in motility. Since over 60 different proteins are involved in the assembly and functioning of flagella, bacterial motility depends on a highly regulated and coordinated expression of structurally complete flagella with functional motor and chemotaxis complexes in order to drive directional motility outward through the soft agar. The class I flhDC operon is required for class II promoter activity, which in turn is required for class III expression including fliC and the chemotaxis genes, and studies have indicated that regulation of expression can occur in a class I-II-III cascade-dependent fashion or directly through class II or even through class III mechanisms (Mellies & Lorenzen, 2014; Tobe et al., 2011) . Interestingly, 20 mM butyrate but neither propionate nor acetate has been shown to increase class I flhDC expression in a manner dependent on the leucine-responsive regulatory protein, while the same concentration of either acetate or propionate alone has been shown to enhance fliC (class III) expression in a manner independent of flhDC (Tobe et al., 2011) . There is also evidence of post-transcriptional modulation of flhDC through QseBC and Hfq (Kendall et al., 2011; Mellies & Lorenzen, 2014 ). Since we see larger changes in FliC expression at the protein level as compared to the genetic level, we cannot rule out the involvement of SCFA-mediated post-transcriptional changes in flagella expression.
DISCUSSION
EHEC encounters SCFAs in varying concentrations and composition during transit through the intestinal tract as well as in food preservatives. The results of our study indicate that EHEC uses these changing SCFA concentrations as cues to modulate numerous genes including flagella and motility genes. When EHEC is exposed to an SCFA mix representative of the small intestine, flagellar genes are significantly upregulated with increases ranging from twofold to fourfold. Flow cytometry and immunoblot analysis confirm the upregulated expression of H7 flagella and the main structural protein, FliC, under these conditions. However, when EHEC is exposed to an SCFA mix representative of the large intestine, flagella genes are dramatically and significantly downregulated 3-fold to 23-fold and immunoblot Fig. 2 . Effect of SCFA mix treatment on FliC (H7) protein expression. EHEC O157 : H7 was stressed with either 30 mM or 172 mM SCFA mix as previously described, followed by protein cell lysis using SDS sample buffer. Samples were run on a 10 % SDS-PAGE, transferred onto a PVDF membrane and then probed using either anti-FliC (H7) or anti-DnaK (loading control). (a) ECL-detected blot images. (b) Quantified protein expression from (a). Data bars represent means±SEM, n=3. *Significantly different from corresponding NaCl control. **Significantly different from 30 mM SCFA treatment; P<0.05, two-way ANOVA. (c) Immunofluorescent microscopic analysis of flagella expression following 30 mM or 172 mM SCFA stress as previously described, using anti-H7 and Alexa Fluor 488-conjugated secondary antibody.
and flow cytometry analysis confirm these results for H7 flagella and FliC. EHEC motility is also significantly downregulated under the lSCFA treatment condition relative to both the sSCFA treatment condition and the NaCl control. These data support the view that exposure to small intestinal levels and composition of SCFA mixes upregulates flagella expression and ensures functional motility during transit within this region of the GIT, while exposure to large intestinal levels and composition of SCFA mixes downregulates flagella expression and motility as EHEC reaches its preferred colonization niche. EHEC is reported to colonize the large intestine with most reports identifying the ascending and transverse colon as the preferential sites of colonization (Bannas et al., 2013; Lewis et al., 2015) . While reported levels and composition of SCFA mixes in the lumen of specific GIT regions are relatively broad and dynamic over time, there appears to be consensus that levels are lowest in the small intestine with 20-40 mM total concentrations, increasing dramatically in the cecum and ascending and transverse colon with levels reaching 160-200 mM and then declining through the descending and sigmoidal regions of the large intestine to concentrations ranging from 70 to 95 mM (Herold et al., 2009; Lawhon et al., 2003; Macfarlane et al., 1992) . In our study, we chose 172 mM total SCFA concentration as representative of the large intestine but, most importantly, close to that typically encountered in the specific site of colonization. Our finding that flagella expression and motility are significantly downregulated under this SCFA mix may represent an energy-conserving response to enhance EHEC's fitness for infection. It may also be consistent with the pathogen's switch from swimming motility to host adhesion. Motility and host cell adhesion fulfil antagonistic functions and pathogens, including EHEC, often employ mechanisms to reciprocally regulate these functions (Akerley et al., 1995; Allison et al., 2012; Li et al., 2001; Morgan et al., 2013; Simms & Mobley, 2008) . Interestingly, Herold et al. reported an increase in the expression of an adhesin protein, iha, in several EHEC strains exposed to a similar lSCFA mix but under shaking rather than static conditions (Herold et al., 2009) . In our study where we used static with 5 % CO 2 culture conditions, we did not see a significant upregulation of iha under 172 mM SCFA but we did note a significant, modest downregulation of iha, under the 30 mM SCFA mix. Changes in oxygen concentration have also been reported to modify EHEC motility and adhesion with increased motility associated with a microaerophilic environment similar to that encountered on the journey through the mucosal epithelial layer toward the epithelial cell surface (Schuller & Phillips, 2010) . Since the focus of our study was to understand how changing concentrations of SCFAs alone could modulate flagella expression and motility, we chose to examine motility and flagella expression under static rather than either microaerophilic or shaking culture conditions. Static conditions are typically used in studies of virulence factor expression in EHEC and are suggested to loosely and broadly define the oxygen concentration in the intestinal lumen (Yin et al., 2011) . It is interesting to note that our microarray data did show significant changes in genes associated with switching between aerobic and anaerobic metabolism (data not shown), and it is possible that SCFAs may also serve to alert the pathogen to changing oxygen concentrations en route. (Momose et al., 2008) . Interestingly, they reported that combinations of lactate and acetate most strongly suppressed EHEC motility under anaerobic conditions and that the same combinations under aerobic conditions increased motility. Takao et al. reported that EHEC, when exposed to 20 mM butyrate, a concentration similar to that found in the large intestine, showed increased expression of flagellar genes, in a leuO-and lrp-dependent manner (Takao et al., 2014) . This response was specific to butyrate and not replicated with either acetate or propionate and all experiments were completed under aerobic culture conditions. The authors concluded that butyrate at 20 mM concentration played a key role in the upregulation of EHEC motility. By contrast, our study focused on understanding how the mix of SCFAs representative of each of the small and large intestines modulates motility and flagella expression. When we examined the effect of each of the SCFAs at the concentrations equal to that of either the sSCFA mix or the lSCFA mix, we found that FliC expression under 30 mM acetate matched that for the 30 mM treatment mix and that treatment with 30 mM propionate resulted in slightly lower FliC expression, suggesting that the response to acetate may be more important in contributing to the overall response to the sSCFA mix. By contrast, at the higher lSCFA concentration, there was no significant difference in the response to the individual SCFAs. It is of interest to note that the concentration of butyrate within the lSCFA mix used in this study is 17 mM and we also observed an increase in FliC expression under 17 mM butyrate treatment alone (data not shown). However, when combined within the mix of SCFAs representative of the large intestine, that increase was not observed and indeed, we saw a decrease in flagellar expression relative to that indicated under the 30 mM sSCFA mix.
In this study, we chose concentrations and compositions reported to be representative of the human small and large intestines and that have been used in other studies to examine the roles of SCFAs in virulence factor expression (Herold et al., 2009; Lawhon et al., 2003; Macfarlane et al., 1992) . However, there is compelling evidence that SCFA concentrations and mixture compositions vary depending on a number of factors including the numbers and composition of intestinal microbiota, diet, gut transit time (with longer transit times associated with increased colonic SCFA concentrations [Macfarlane et al., 1992] ) and even time of day. The two major phyla that dominate the human GIT are Bacteriodetes and Firmicutes and there is a strong correlation between a number of diseases such as obesity and diabetes and shifts in the gut microbiota profiles (Turnbaugh et al., 2009 ). An obesity mouse model study revealed a strong correlation between diets rich in saturated fats and complex oligosaccharides and an increase in the number of gut Firmicutes (Turnbaugh et al., 2009) . Bacteroidetes tend to produce primarily acetate and propionate, whereas Firmicutes tend to produce more butyrate (den Besten et al., 2013) , and thus changes in the gut microbiota profile that favour one or the other should result in changes in the proportions of SCFAs produced and possibly the total concentrations. Zumbrun et al. examined the effect of a high-fat diet that increased butyrate production by normal gut flora and decreased levels of commensal E. coli, and found that mice on high-fat diets showed enhanced colonization (10-fold to 100-fold) by EHEC 86-24 and 25 % greater mortality that they linked to increased expression of globotriaosylceramide, the Shiga toxin receptor on epithelial cells (Zumbrun et al., 2013) . Based on our findings, an important next step would be to examine whether conditions that are associated with dysbiosis of gut microbiota such as obesity or diabetes could influence EHEC motility and/or colonization.
Diets can also influence levels and composition of intestinal SCFAs. It has been reported that diets rich in starch, wheat and oat bran tend to yield more butyrate through fermentation, while consumption of pectin-containing foods typically yields more acetate through fermentation (Cummings & Macfarlane, 1991; Gilbert et al., 2008; Roy et al., 2006) . Food additives may also alter intestinal levels of SCFAs. It is, therefore, tempting to ask whether diet could also influence susceptibility to EHEC infection through the SCFAmediated modulation of motility and flagella expression.
Motility provides a pathogen with a profound advantage in transiting through the GIT, permitting the pathogen to avoid detrimental locations and to find more favourable niches. Consequently, microenvironmental cues that modulate EHEC motility may play a key role in its pathogenesis. Since we have shown that SCFA mixtures with different concentrations and different ratios of the individual components, representative of different regions of the GIT, significantly modulate EHEC flagella expression and motility, the factors that influence those SCFA levels and ratios may also influence EHEC motility and pathogenicity. It is well known that modification of the gut microbiota can alter the SCFA ratios and levels and therefore factors such as diet, probiotics and prebiotics and prior antibiotic treatment courses could potentially influence EHEC pathogenesis (Fukata et al., 1999; Gilbert et al., 2008; Roy et al., 2006; Zumbrun et al., 2013) . Our study suggests that these factors can serve to modulate EHEC motility, a property that plays a critical role in pathogenesis. Secondly, SCFAs have long been used as an intervention step in food processing (Ricke, 2003) and the results of our study suggest that these treatments could enhance EHEC virulence rather than reduce it.
